Gynecologic Oncology

Editorial board
pp. iii-iii(1)

Reply
pp. 498a-498a(1)
Authors: Flynn P.; Paul J.; Cruickshank D.

Reply
pp. 499a-500(2)
Authors: Ayhan A.; Taskiran C.

Letter to the editor
pp. 495a-496(2)
Authors: Querleu D.; Occelli B.; Leblanc E.; Narducci F.

Importance of the general practitioner in the early detection of ovarian cancer
pp. 491a-492(2)
Authors: Petignat P.; Joris F.; Faltin D.

Early ovarian cancer-time for a rethink on stage?
pp. 235-237(3)
Author: Green J.A.

MDM2 sensitizes a human ovarian cancer cell line
pp. 238-244(7)
Authors: Mi R.-R.; Ni H.

Technical modification of the nerve-sparing laparoscopy-assisted vaginal radical hysterectomy type 3 for better reproducibility of this procedure*
pp. 245-247(3)
Author: Possover M.

V- and 1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients
pp. 248-257(10)
Authors: Davidson B.; Goldberg I.; Reich R.; Tell L.; Dong H.P.; Trope' C.G.; Risberg B.; Kopolovic J.

The detection of stage I ovarian cancer by three-dimensional sonography and power Doppler
pp. 258-264(7)
Authors: Kurjak A.; Kupesic S.; Sparac V.; Prka M.; Bekavac I.

Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC
pp. 265-272(8)
Authors: Kim C.-K.; Choi E.-J.; Choi S.-H.; Park J.-S.; Haider K.H.; Ahn W.S.

Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients
pp. 273-281(9)
Authors: Moilanen J.; Lassus H.; Leminen A.; Vaheri A.; Butzow R.; Carpen O.

Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix
pp. 282-289(8)
Authors: Alfsen G.C.; Reed W.; Abeler V.M.

Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer
pp. 290-296(7)
Authors: Buist M.R.; Pijpers R.J.; van Lingen A.; van Diest P.J.; Dijkstra J.; Kenemans P.; Verheijen R.H.M.

Three-dimensional coculture of endometrial cancer cells and fibroblasts in human placenta derived collagen sponges and expression matrix metalloproteinases in these cells*
pp. 297-304(8)
Authors: Tanaka R.; Saito T.; Ashihara K.; Nishimura M.; Mizumoto H.; Kudo R.

Frozen section examination of the endocervical margin of cervical conization specimens
pp. 305-309(5)
Authors: Rouzier R.; Feyereisen E.; Constancis E.; Haddad B.; Dubois P.; Paniel B.-J.

Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women
pp. 310-317(8)
Authors: Hernandez-Hernandez D.M.; Ornelas-Bernal L.; Guido-Jimenez M.; Apresa-Garcia T.; Alvarado-Cabrero I.; Salcedo-Vargas M.; Mohar-Betancourt A.; Garcia-Carranca A.

Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity
pp. 318-324(7)
Authors: Lopata A.; Agresta F.; Quinn M.A.; Smith C.; Ostor A.G.; Salamonsen L.A.

Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignancies
pp. 325-330(6)
Authors: Gold M.A.; Walker J.L.; Berek J.S.; Hallum A.V.; Garcia D.J.; Alberts D.S.

Reduced Fhit expression in cervical carcinoma: correlation with tumor progression and poor prognosis
pp. 331-337(7)
Authors: Huang L.-W.; Chao S.-L.; Chen T.-J.

Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary
pp. 338-341(4)
Authors: Mori Y.; Nishii H.; Takabe K.; Shinozaki H.; Matsumoto N.; Suzuki K.; Tanabe H.; Watanabe A.; Ochiai K.; Tanaka T.

Continuous abdominal fascial closure: a randomized controlled trial of poly(l-lactide/glycolide)
pp. 342-347(6)
Authors: Orr J.W.; Montz F.J.; Barter J.; Schaitzberg S.D.; Delmore J.E.; Dodson M.K.; Gallup D.; Yeh K.A.; Elias E.G.

Multiple uterine angioleiomyomas in a woman presenting with severe menorrhagia
pp. 348-352(5)
Authors: Hsieh C.-H.; Lui C.-C.; Huang S.-C.; Ou Y.-C.; ChangChien C.-C.; Lan K.-C.; Huang K.-H.

MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus
pp. 353-357(5)
Authors: Popiolek D.; Yee H.; Levine P.; Vamvakas E.; Demopoulos R.I.

Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization
pp. 358-365(8)
Authors: Costa S.; Simone P.D.; Venturoli S.; Cricca M.; Zerbini M.L.; Musiani M.; Terzano P.; Santini D.; Cristiani P.; Syrjanen S.; Syrjanen K.

Measurement of Brn-3a levels in Pap smears provides a novel diagnostic marker for the detection of cervical neoplasia
pp. 366-371(6)
Authors: Sindos M.; Ndisang D.; Pisal N.; Chow C.; Singer A.; Latchman D.S.

Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis
pp. 372-377(6)
Authors: Amant F.; Vloeberghs V.; Woestenborghs H.; Moerman P.; Vergote I.

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma
pp. 378-381(4)
Authors: Gemignani M.L.; Schlaerth A.C.; Bogomolniy F.; Barakat R.R.; Lin O.; Soslow R.; Venkatraman E.; Boyd J.

Recurrent endometrial polyps in postmenopausal breast cancer patients on tamoxifen
pp. 382-386(5)
Authors: Biron-Shental T.; Tepper R.; Fishman A.; Shapira J.; Cohen I.

Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins
pp. 387-389(3)
Authors: Itsukaichi M.; Kurata H.; Matsushita M.; Watanabe M.; Sekine M.; Aoki Y.; Tanaka K.

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study
pp. 390-396(7)
Authors: Eisenkop S.M.; Spirtos N.M.; Friedman R.L.; Lin W.-C.M.; Pisani A.L.; Perticucci S.

Breast cancer metastatic to abdomen and pelvis: role of surgical resection*
pp. 397-401(5)
Authors: Eitan R.; Gemignani M.L.; Venkatraman E.S.; Barakat R.R.; Abu-Rustum N.R.

The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus
pp. 402-406(5)
Authors: Wang L.; Felix J.C.; Lee J.L.; Tan P.Y.; Tourgeman D.E.; O'Meara A.T.; Amezcua C.A.

Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants
pp. 407-412(6)
Authors: Lackman F.; Carey M.S.; Kirk M.E.; McLachlin C.M.; Elit L.

Enhancement of sensitivity to cisplatin by orobol is associatedwith increased mitochondrial cytochrome c releasein human ovarian carcinoma cells
pp. 413-420(8)
Authors: Isonishi S.; Saitou M.; Yasuda M.; Ochiai K.; Tanaka T.

A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer*
pp. 421-424(4)
Authors: Oishi T.; Kigawa J.; Fujiwara K.; Fujiwara M.; Numa F.; Aotani E.; Katsumata N.; Kohno I.; Kato H.; Terakawa N.

Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy*
pp. 425-430(6)
Authors: Khalifa M.A.; Dodge J.; Covens A.; Osborne R.; Ackerman I.

The effects of CO₂ pneumoperitoneum on the survival of women with persistent metastatic ovarian cancer
pp. 431-434(4)
Authors: Abu-Rustum N.R.; Sonoda Y.; Chi D.S.; Teoman H.; Dizon D.S.; Venkatraman E.; Barakat R.R.

Urinary matrix metalloproteinases as a potential screening test for gynecologic malignancies
pp. 435-442(8)
Authors: Bazzett L.B.; Magnus M.; Taylor D.D.; Gercel-Taylor C.

Microinvasive squamous cell carcinoma of the cervix: immunohistochemically detected prognostic factors in a case with poor clinical outcome
pp. 443-445(3)
Authors: Kohlberger P.; Edwards L.; Hacker N.F.

Abdominal wall metastasis of a cervical adenocarcinoma at the laparoscopic trocar insertion site after ovarian transposition: case report and review of the literature
pp. 446-449(4)
Authors: Picone O.; Aucouturier J.S.; Louboutin A.; Coscas Y.; Camus E.

Leiomyosarcoma of the broad ligament: a case report and literature review
pp. 450-452(3)
Authors: Shah A.; Finn C.; Light A.

Fused functional-anatomic images of metastatic cancer of cervix obtained by a combined gamma camera and an X-ray tube hybrid system with an illustrative case and review of the ¹⁸F-fluorodeoxyglucose literature
pp. 453-457(5)
Authors: Aizer-Dannon A.; Bar-Am A.; Ron I.G.; Flusser G.; Even-Sapir E.

Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus
pp. 458-461(4)
Authors: Montagut C.; Marmol M.; Rey V.; Ordi J.; Pahissa J.; Rovirosa A.; Gascon P.; Mellado B.

A case of ovarian cancer with remote metastases, with emphasis on changes in tumor marker values
pp. 462-465(4)
Authors: Mikami M.; Suzuki A.; Takehara K.; Komiyama S.; Ishikawa M.; Hirose T.

Radical trachelectomy via a trans-sacral approach: a case report
pp. 466-470(5)
Authors: Sonoda Y.; Papageorgiou T.; Taieb S.; Querleu D.; Leblanc E.

Symptomatic skeletal muscle metastasis and elephantiastic lymphedema in a patient with recurrent ovarian carcinoma
pp. 471-473(3)
Authors: Foldi M.; Randelzhofer B.; Gitsch G.

A case of lymphoma occurring in an ovarian teratoma
pp. 474-477(4)
Authors: McKelvey A.; McKenna D.; McManus D.; Joyce M.

A case report of multicentric verrucous carcinoma of the female genital tract
pp. 478-481(4)
Authors: Yorganci A.; Serinsoz E.; Ensari A.; Sertcelik A.; Ortac F.

Gangliocytic paraganglioma arising from mature cystic teratoma of the ovary
pp. 482-485(4)
Authors: Mahdavi A.; Silberberg B.; Malviya V.K.; Braunstein A.H.; Shapiro J.

Mullerian adenosarcoma of vagina arising in persistent endometriosis: report of a case and review of the literature
pp. 486-490(5)
Authors: Liu L.; Davidson S.; Singh M.

BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis
pp. 491-491(1)
Authors: Piek J.M.J.; Verheijen R.H.M.; Kenemans P.; Massuger L.F.; Bulten H.; van Diest P.J.

Sentinel lymph node procedure in early vulvar cancer
pp. 492-493(2)
Authors: Boran N.; Kayikcioglu F.; Kir M.

Vesicocutaneous fistula mimicking an abdominal wall abscess 2 years after radical abdominal hysterectomy
pp. 494-494(1)
Authors: Petru E.; Herzog K.; Kurschel S.; Tamussino K.; Winter R.

Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomy
pp. 495-495(1)
Author: Holub Z.

Reply
pp. 496-497(2)
Authors: Chu C.S.; Rubin S.C.

Flynn et al.: does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?
pp. 498-498(1)
Author: Omura G.A.

Lett to the editor
pp. 499-499(1)
Authors: Mell L.K.; Mundt A.J.